Cross-institution positioning
Feb 12, 2026Strong institutional reduction. 2 exited across 2 comparable institutions.
Source: Schedule 13 researchZYME Institutional Ownership
Zymeworks Inc.
Latest stored close $25.79 as of Oct 9, 2026 View live quote ↗
STOCKNODE Outlook
Sell
32/100
3 tracked · 2 comparable
Latest filing
Feb 12, 2026
Positive breadth
1 positive · 2 negative
Recent close
$25.79
Research confidence
Limited
Institutional Research 20/100 · 0 accumulating · 2 reducing / exited
Ownership history
Reported ownership % history
Latest filing Feb 12, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating0
Newly reported1
Reducing / exited
2
52-week position
—
Institutional Intelligence
Why STOCKNODE says Sell
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Sell 32/100
Confidence:Limited
Why this signal
- 0 tracked institutions accumulating versus 2 reducing/exited.
Institutional
28/100
Insiders
45/100
Fundamentals
30/100
Events
50/100
Quarterly 13F activity
Jun 30, 20261 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Oct 9, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Sep 23, 20263 non-amendment material events in the last 90 days; 1 capital-related filing/event (0 equity-related, 1 debt-related); Latest classified evidence: Material definitive agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 6, 2026Revenue -90.6% YoY; Net income -2,043.0% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 66% through its reported 52-week range; +63.5% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Morgan Stanley.
Filed Feb 12, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Feb 12, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
BlackRock
Filed Jul 16, 2025
Direction locked
BlackRock
Filed Jan 29, 2024
Direction locked
Goldman Sachs Group
Filed Feb 10, 2023
Direction locked
Morgan Stanley
Filed Feb 12, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
BlackRock
Filed Jul 16, 2025
BlackRock
Filed Jan 29, 2024
Goldman Sachs Group
Filed Feb 10, 2023
Morgan Stanley
Filed Feb 12, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales11 reporting owner(s)
90-day purchase breadth0
90-day sale breadth1
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Schayowitz Adam | MExercise or conversion of derivative · derivative | Restricted Stock Unit | 37.0K | $0.00 | Direct | Oct 9, 2026 |
| Oct 9, 2026 | Schayowitz Adam | SOpen-market or private sale | Common Stock | 13.8K | $25.85 | Direct | Oct 9, 2026 |
| Oct 9, 2026 | Schayowitz Adam | MExercise or conversion of derivative | Common Stock | 37.0K | $0.00 | Direct | Oct 9, 2026 |
| Jul 6, 2026 | Hollywood Mark | AGrant, award, or other acquisition | Common Stock | 939 | $22.22 | Direct | Jul 6, 2026 |
| May 13, 2026 | Schneider Paul R | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 119.0K | $0.00 | Direct | May 15, 2026 |
| May 13, 2026 | Schneider Paul R | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 178.0K | $0.00 | Direct | May 15, 2026 |
| Apr 9, 2026 | Schayowitz Adam | AGrant, award, or other acquisition · derivative | Performance Stock Unit | 76.0K | $0.00 | Direct | Apr 10, 2026 |
| Apr 9, 2026 | Schayowitz Adam | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 47.0K | $0.00 | Direct | Apr 10, 2026 |
| Apr 9, 2026 | Schayowitz Adam | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Apr 10, 2026 |
| Apr 9, 2026 | Platshon Scott | AGrant, award, or other acquisition · derivative | Performance Stock Unit | 76.0K | $0.00 | Direct | Apr 10, 2026 |
| Apr 9, 2026 | Platshon Scott | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 47.0K | $0.00 | Direct | Apr 10, 2026 |
| Apr 9, 2026 | Platshon Scott | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Apr 10, 2026 |
| Apr 6, 2026 | Stafford Kristin | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 50.0K | $0.00 | Direct | Apr 7, 2026 |
| Apr 6, 2026 | Stafford Kristin | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 119.0K | $0.00 | Direct | Apr 7, 2026 |
| Apr 6, 2026 | Stafford Kristin | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 178.0K | $0.00 | Direct | Apr 7, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events1
90-day capital-related1
90-day equity-related0
90-day debt-related1
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 23, 2026 | 8-K | 1.01, 2.01, 2.03, 7.01, 9.01 | Material definitive agreement; Acquisition or disposition of assets; New direct financial obligation; Regulation FD disclosure; Financial statements / exhibits | Debt | Filing |
| Aug 25, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Aug 6, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jun 29, 2026 | 8-K | 1.01, 7.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 14, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| May 7, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Apr 1, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Mar 2, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Mar 2, 2026 | 8-K | 1.01, 2.03, 7.01, 9.01 | Material definitive agreement; New direct financial obligation; Regulation FD disclosure; Financial statements / exhibits | Debt | Filing |
| Mar 2, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jan 12, 2026 | 8-K | 2.02, 5.02, 8.01, 9.01 | Results of operations / financial condition; Director or executive change; Other event; Financial statements / exhibits | — | Filing |
| Dec 30, 2025 | 8-K | 5.07 | Shareholder vote results | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$4.6M
Q2 2026
-90.6% YoY 10-Q filed Aug 6, 2026
Operating income
$-42.2M
Q2 2026
-6,158.2% YoY 10-Q filed Aug 6, 2026
Operating margin
-919.0%
Q2 2026
-917.6 pts YoY 10-Q filed Aug 6, 2026
Net income
$-45.0M
Q2 2026
-2,043.0% YoY 10-Q filed Aug 6, 2026
Diluted EPS
$-0.62
Q2 2026
-2,166.7% YoY 10-Q filed Aug 6, 2026
Operating cash flow
$-77.7M
YTD through Jun 30, 2026
-996.2% YoY 10-Q filed Aug 6, 2026
Free cash flow
$-77.9M
YTD through Jun 30, 2026
-1,057.3% YoY 10-Q filed Aug 6, 2026
Cash & equivalents
$179.4M
As of Jun 30, 2026
+82.6% YoY 10-Q filed Aug 6, 2026
Assets
$397.0M
As of Jun 30, 2026
-2.8% YoY 10-Q filed Aug 6, 2026
Liabilities
$316.6M
As of Jun 30, 2026
+328.5% YoY 10-Q filed Aug 6, 2026
Stockholders’ equity
$80.4M
As of Jun 30, 2026
-76.0% YoY 10-Q filed Aug 6, 2026
Shares outstanding
71.0M
As of Aug 4, 2026
-5.6% YoY 10-Q filed Aug 6, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $4.6M | -90.6% |
| Ended Mar 31, 2026 | $2.4M | -91.1% |
| Ended Sep 30, 2025 | $27.6M | +72.6% |
| Ended Jun 30, 2025 | $48.7M | +153.2% |
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $106.0M | +38.9% |
| Ended Dec 31, 2024 | $76.3M | +0.4% |
| Ended Dec 31, 2023 | $76.0M | -81.6% |
| Ended Dec 31, 2022 | $412.5M | +1,446.0% |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$26.05
View live quote ↗
52-week low
$15.79
Sep 17, 2025
52-week high
$31.34
Sep 3, 2026
Below 52-week high
16.9%
1W return
-7.3%
1M return
+3.7%
3M return
+12.0%
6M return
+13.9%
YTD return
-1.1%
1Y return
+63.5%
30-day volatility
52.9%
90-day volatility
47.6%
1Y max drawdown
-23.6%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 11 filing(s) · 8 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Morgan Stanley CIK0000895421 | Dec 31, 2025 observed Feb 12, 2026 filed · 43d Schedule 13G amendment | Exit below reporting threshold | 2.5M -1.5M | 3.40% -2.40 pts | $26.33 | $23.17 | $25.79 |
| BlackRock CIK0002012383 | Jun 30, 2025 observed Jul 16, 2025 filed · 16d Schedule 13G amendment | Earliest Schedule 13G amendment found | 3.6M | 4.80% | $12.55 | $13.52 | $25.79 |
| Morgan Stanley CIK0000895421 | Mar 31, 2025 observed May 7, 2025 filed · 37d Schedule 13G amendment | Reported reduction | 4.1M -787.3K | 5.80% -1.10 pts | $11.91 | $11.34 | $25.79 |
Explore more institutional activity
Related research
Compare ZYME with other securities showing similar institutional activity or recent accumulation across several tracked institutions.